JAZZ

Jazz Pharmaceuticals plc

+$1.7B

Net Activity

Institutions Holding

570

Popularity Rank

#942

Avg Weight

0.20%

Total Value

$12.4B

Ownership Trend

570 institutions currently hold JAZZ, with 307 net buyers and 242 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

242

Net Buying Institutions

307

Key Holders

View all 570 holding institutions

Quarterly Activity

Recent Activity

+$7.8B

Total Buy Value

$3.7B

Total Sell Value

New buy81
Trim163
Add226
Sold out79

307

Net Buyers

242

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$1.99M

Total Est. Value

8K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
Bruce C Cozadd2026-07-01$1.44M
Smith Mark Douglas2026-06-15$267K
Patil Neena M2026-06-10$278K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding Jazz Pharmaceuticals plc (JAZZ)?
Major stakeholders currently include BlackRock, Inc. ($1.1B), Vanguard Portfolio Management LLC ($564.0M), Capital World Investors ($505.4M). Based on the latest 13F filings, there are a total of 570 tracked investment funds and institutions maintaining positions in JAZZ.
What is the overall institutional sentiment toward JAZZ recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.7B, driven by 307 managers accumulating shares while 242 reduced their exposure.
Which institutions have been selling or reducing their JAZZ positions?
In the latest period, 163 funds trimmed their holdings, and 79 managers completely exited their positions. The aggregate reported sell value was $3.7B.
Are there any notable investors adding JAZZ to their portfolios?
Yes, buying activity remains notable. 81 institutions opened new positions in {ticker}, and 226 existing holders added to their shares. The total reported buy value for the quarter amounted to $7.8B.

Related Stocks